|
07 Dec 2007 |
Intercell Submits Marketing Authorization Application (MAA) to EMEA for Licensure of Japanese Enceph
|
|
06 Dec 2007 |
AVANT Immunotherapeutics Achieves Immune Responses Against Cholera, Typhoid and Enterotoxigenic E. coli with a Single-Dose, Oral Combination Vaccine
|
|
06 Dec 2007 |
Nventa completes enrollment and initial dosing of second cohort in phase 1 hspE7 safety trial
|
|
04 Dec 2007 |
SSI, Intercell and Aeras announce start of clinical trial for novel vaccine candidate against TB
|
|
29 Nov 2007 |
Bavarian Nordic A/S reports positive data from first EUA enabling study with IMVAMUNE(R) smallpox vaccine
|
|
29 Nov 2007 |
Cytos Biotechnology announces start of two phase II studies
|
|
28 Nov 2007 |
Oralair(R) Grasses: Positive results of VO52.06 paediatric study
|
|
27 Nov 2007 |
Nventa updates progress with new HspE7 in Phase 1 trial in cervical dysplasia
|
|
27 Nov 2007 |
Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine
|
|
23 Nov 2007 |
New data published in The Lancet show GSK's rotavirus vaccine Rotarix(R) offers sustained and broad protection against all common circulating rotavirus types
|
|
22 Nov 2007 |
Diamyd Executes Agreement With US National Institutes of Health For a Type 1 Diabetes Trial With The Experimental Diamyd(R) Diabetes Vaccine
|
|
22 Nov 2007 |
New promising results published on Pharmexa's PADRE(R) epitope in Alzheimer's vaccine
|
|
20 Nov 2007 |
Cytos Biotechnology presents encouraging phase IIa study results for its melanoma vaccine CYT004-MelQbG10
|
|
19 Nov 2007 |
Curalogic has commenced a Phase III clinical study with the grass product
|
|
19 Nov 2007 |
AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine to Enter Phase 1 Safety Study Funded by the NIH
|
|
19 Nov 2007 |
Pharmexa provides update on the HeptoVax trial of GV1001 in liver cancer
|
|
15 Nov 2007 |
Sanofi Pasteur and Acambis join forces to bring West Nile vaccine to market
|
|
15 Nov 2007 |
New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis
|
|
13 Nov 2007 |
AVAX Technologies announces the initiation of its Phase III Registration trial of M-Vax(R) in Metastatic Melanoma
|
|
12 Nov 2007 |
Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting
|
|
09 Nov 2007 |
Promising clinical results from new HIV vaccine
|
|
07 Nov 2007 |
Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
|
|
07 Nov 2007 |
Sanofi Pasteur initiates phase II trial of cell
|
|
06 Nov 2007 |
Presentation of phase IIa results for Cytos Biotechnology’s hypertension vaccine at the American Heart Association Scientific Sessions 2007
|
|
06 Nov 2007 |
GlobeImmune Announces Presentation of Results from a Randomized Phase 1b Study of the GI-5005 Tarmogen in Patients with Chronic Hepatitis C Infection
|
